Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Current Problems in Cardiology|February 3, 2022
Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural ManagementIslam Eljilany, Hazem Elewa, Daoud Al-Badriyeh
Seminars in Thrombosis and Hemostasis|May 29, 2016
Triple Oral Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Stenting: Searching for the Best CombinationHazem Elewa, Dina Ahmed, Geoffrey D Barnes
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 30, 2021
The Dilemma of Peri-Procedural Warfarin Management: A Narrative ReviewIslam Eljilany, Ahmed El-Bardissy, Hazem Elewa
Journal of Cardiovascular Pharmacology and Therapeutics|October 6, 2017
Appropriateness of Dabigatran and Rivaroxaban Prescribing in Qatar: A 5-Year ExperienceHazem Elewa, Honain El-Makaty, Zainab Ali
Current Treatment Options in Cardiovascular Medicine|February 25, 2016
Cancer-Associated Venous ThromboembolismHazem Elewa, Riham Elrefai, Geoffrey D Barnes
Journal of Cardiovascular Pharmacology and Therapeutics|February 7, 2020
Economic Evaluations of CYP2C19 Genotype-Guided Antiplatelet Therapy Compared to the Universal Use of Antiplatelets in Patients With Acute Coronary Syndrome: A Systematic ReviewSawsan AlMukdad, Hazem Elewa, Daoud Al-Badriyeh
International Journal of Hematology|June 22, 2014
Telephone versus office-based management of warfarin: impact on international normalized ratios and outcomesLaura G Stoudenmire, Christina E DeRemer, Hazem Elewa
Frontiers in Pharmacology|March 12, 2025
Association between CYP2C19 polymorphism and proton pump inhibitors adverse drug reactions: a narrative reviewAsmaa Ibrahim, Kazeem Yusuff, Ahmed Awaisu, et al.
International Journal of Clinical Pharmacy|March 5, 2022
Warfarin dosing strategies evolution and its progress in the era of precision medicine, a narrative reviewAmr Mohamed Fahmi, Hazem Elewa, Islam El Jilany
The Annals of Pharmacotherapy|September 19, 2017
Direct Oral Anticoagulant Use in Atypical Thrombosis-Related ConditionsClement Chang, Mario Hoyos, Yaw Owusu, et al.
Pageof 8